• This record comes from PubMed

Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

. 2009 Aug ; 58 (8) : 503-12. [epub] 20090307

Language English Country Switzerland Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

OBJECTIVE: It is an open question whether multifunctional galectin-3 can be a serum marker in inflammatory bowel disease. METHODS: Western blots and commercial ELISA detected and quantitated the lectin immunocytochemistry using double labeling localized it in tissue sections. RESULTS: Serum concentrations were significantly increased in specimen of patients with active and remission-stage ulcerative colitis and Crohn's disease, associated with emerging positivity of CD14(+) cells. CONCLUSION: Enhanced concentration of galectin-3 in serum reflects presence of disease and points to its involvement in the pathogenesis.

See more in PubMed

Clin Exp Immunol. 2007 Oct;150(1):13-21 PubMed

Glycoconj J. 2004;19(7-9):575-81 PubMed

Thyroid. 2008 Jul;18(7):705-12 PubMed

J Histochem Cytochem. 1990 Nov;38(11):1625-31 PubMed

Biochemistry. 2005 Sep 20;44(37):12564-71 PubMed

Gastroenterology. 1990 Mar;98(3):694-702 PubMed

Inflamm Bowel Dis. 2007 Oct;13(10):1202-11 PubMed

J Clin Immunol. 2001 Sep;21(5):348-56 PubMed

Immunol Rev. 2005 Aug;206:260-76 PubMed

J Clin Microbiol. 2005 Jul;43(7):3380-9 PubMed

Biochim Biophys Acta. 2006 Apr;1760(4):616-35 PubMed

Bone. 2008 Nov;43(5):945-50 PubMed

Eur J Gastroenterol Hepatol. 1997 Sep;9(9):893-9 PubMed

Lab Invest. 1993 Aug;69(2):238-49 PubMed

Gastroenterol Clin North Am. 2005 Sep;34(3):401-12, vii-viii PubMed

Biochim Biophys Acta. 2008 Apr;1780(4):716-22 PubMed

Immunol Rev. 2005 Aug;206:149-59 PubMed

Cytometry A. 2008 Feb;73(2):139-47 PubMed

J Gastroenterol. 2006 Jan;41(1):10-6 PubMed

Eur J Gastroenterol Hepatol. 2002 Feb;14(2):145-52 PubMed

Histochemistry. 1991;95(3):269-77 PubMed

Ann N Y Acad Sci. 2005 Jun;1051:787-98 PubMed

Clin Cancer Res. 2000 Apr;6(4):1389-93 PubMed

Crit Rev Immunol. 2006;26(1):43-79 PubMed

Circulation. 2004 Nov 9;110(19):3121-8 PubMed

J Immunol. 2000 Aug 15;165(4):2156-64 PubMed

Folia Biol (Praha). 2007;53(4):109-28 PubMed

Eur J Cancer. 2004 Oct;40(15):2324-30 PubMed

J Pediatr Gastroenterol Nutr. 2002 May-Jun;34 Suppl 1:S33-9 PubMed

Histochem Cell Biol. 2008 Sep;130(3):567-81 PubMed

Immunol Lett. 2004 May 15;93(2-3):97-108 PubMed

Eur J Biochem. 1997 Feb 1;243(3):543-76 PubMed

J Cancer Res Clin Oncol. 1999 Aug-Sep;125(8-9):461-74 PubMed

Folia Biol (Praha). 1999;45(4):157-62 PubMed

Inflamm Bowel Dis. 2007 Jan;13(1):91-6 PubMed

Inflamm Bowel Dis. 2006 Jun;12(6):429-36 PubMed

FEBS J. 2007 Jul;274(13):3233-56 PubMed

J Biol Chem. 2001 Sep 21;276(38):35917-23 PubMed

J Biol Chem. 2004 Mar 19;279(12):10841-7 PubMed

J Immunol. 2001 Sep 1;167(5):2651-6 PubMed

Folia Microbiol (Praha). 2001;46(6):565-72 PubMed

Antimicrob Agents Chemother. 2008 Feb;52(2):427-34 PubMed

N Engl J Med. 2005 Dec 8;353(23):2462-76 PubMed

J Dig Dis. 2007 Nov;8(4):171-8 PubMed

Inflamm Bowel Dis. 2006 Apr;12(4):304-10 PubMed

Int Arch Allergy Immunol. 2003 Jul;131(3):209-11 PubMed

Gastroenterology. 2001 Feb;120(3):622-35 PubMed

N Engl J Med. 1987 Dec 24;317(26):1625-9 PubMed

Histol Histopathol. 1993 Apr;8(2):369-83 PubMed

Inflamm Bowel Dis. 2006 Jul;12(7):588-97 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...